Nourished: Evolving the conversation around gummy nutraceutical bioavailability

While the market for gummy nutraceuticals is expected to grow​ at a CAGR of 11.8% from 2022 to 2030, recent media​ reports have drawn attention to the potential limitations of the format including high sugar content and shelf-life constraints. There are also concerns that gummies may provide significant overages due to their rapid breakdown within the body, which can pose a potential health risk to certain groups​.

In a 2019 study​ investigating the bioequivalence of vitamin D gummies and tablets, researchers from the University of South Carolina observed that VitaFusion vitamin D gummies had a greater bioavailability than the studied tablets. On the other hand, a pilot study​ conducted in 2020 found that both gummies and tablets showed similar absorption of vitamins E and 12, while folate was more rapidly absorbed via gummy form.

Melissa Snover, founder and CEO of Nourished, agrees that concerns around the bioavailability of gummies result from limitations typically associated with the delivery format.

“Unlike pills, gummies traditionally can’t pack in as many vitamins and minerals due to space and taste constraints,” she told NutraIngredients. “Additionally, gummies often contain added sugars and preservatives, which can detract from their healthiness and raise concerns for those with dietary restrictions.”

Yet, she argues that with a growing prevalence of nutritional deficiencies in the Western diet and growing food insecurity, gummies may enhance consumer experience and improve adherence.